Which pharmaceutical companies have the most SPCs in Finland?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source


New patent for HIKMA drug COMBOGESIC IV

Annual Drug Patent Expirations for COMBOGESIC+IV Combogesic Iv is a drug marketed by Hikma and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for HIKMA drug COMBOGESIC IV appeared first on DrugPa…


Biotechblog